Education
About Us
Working with TipRanks
Follow Us
Klaria Pharma Holding AB (SE:KLAR)
:KLAR
RESEARCH TOOLSreports
KLAR Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr0.27 - kr1.76
Previous CloseN/A
Volume243.47K
Average Volume (3M)637.93K
Market Cap
kr137.75M
Enterprise Valuekr58.58M
Total Cash (Recent Filing)kr1.97M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta2.41
Next Earnings
Nov 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding245,976,150
10 Day Avg. Volume691,729
30 Day Avg. Volume637,932
Financial Highlights & Ratios
PEG Ratio-0.16
Price to Book (P/B)12.62
Price to Sales (P/S)18.57
P/FCF Ratio-3.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
KLAR FAQ
What was Klaria Pharma Holding AB’s price range in the past 12 months?
Klaria Pharma Holding AB lowest stock price was kr0.27 and its highest was kr1.76 in the past 12 months.
What is Klaria Pharma Holding AB’s market cap?
Klaria Pharma Holding AB’s market cap is kr137.75M.
When is Klaria Pharma Holding AB’s upcoming earnings report date?
Klaria Pharma Holding AB’s upcoming earnings report date is Nov 26, 2025 which is in 68 days.
How were Klaria Pharma Holding AB’s earnings last quarter?
Klaria Pharma Holding AB released its earnings results on Aug 28, 2025. The company reported -kr0.139 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.139.
Is Klaria Pharma Holding AB overvalued?
According to Wall Street analysts Klaria Pharma Holding AB’s price is currently Overvalued.
Does Klaria Pharma Holding AB pay dividends?
Klaria Pharma Holding AB does not currently pay dividends.
What is Klaria Pharma Holding AB’s EPS estimate?
Klaria Pharma Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Klaria Pharma Holding AB have?
Klaria Pharma Holding AB has 245,976,150 shares outstanding.
What happened to Klaria Pharma Holding AB’s price movement after its last earnings report?
Klaria Pharma Holding AB reported an EPS of -kr0.139 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 11.25%.
Which hedge fund is a major shareholder of Klaria Pharma Holding AB?
Currently, no hedge funds are holding shares in SE:KLAR
Company Description
Klaria Pharma Holding AB
Klaria Pharma Holding AB (KLAR) is a pharmaceutical company focused on the development of innovative drug delivery solutions. The company specializes in the creation of fast-acting medications using its proprietary drug delivery platform, which aims to improve the administration of treatments for acute and emergency conditions. Klaria Pharma's technology leverages thin film formulations that allow medications to be absorbed quickly and efficiently, bypassing the gastrointestinal tract, and offering a novel approach to delivering therapeutic agents.